Trimethylammonium

Trimethylammonium

SCHEMBL7802297

CCNc1ccccc1Cl.CN(C)C

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.45
KDM4E B2RXH2 1/20 0.45
GAA P10253 1/20 0.45
GFER P55789 1/20 0.45
IDO1 P14902 2/20 0.44
MAPT P10636 2/20 0.44
ADRA2B P18089 1/20 0.44
ADRA2C P18825 1/20 0.44
KMT2A Q03164 4/20 0.40
MEN1 O00255 3/20 0.40
HTT P42858 2/20 0.40
MAPK1 P28482 1/20 0.40
RAB9A P51151 1/20 0.40
LMNA P02545 3/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
KCNQ2 O43526 1/20 0.39
TAS1R3 Q7RTX0 1/20 0.39
TAS1R1 Q7RTX1 1/20 0.39
TAAR1 Q96RJ0 1/20 0.38
MITF O75030 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1116563 0.94 IDO1 (0.48) ALDH1A1KDM4EGAAGFERIDO1
SCHEMBL28887965 0.88 IDO1 (0.44) ALDH1A1KDM4EGAAGFERIDO1
SCHEMBL7801497 0.84 ALDH1A1 (0.55) ALDH1A1KDM4EGAAGFERIDO1
Pyridine SCHEMBL7795579 0.81 ROCK2 (0.43) ALDH1A1KDM4EIDO1MAPTADRA2B
SCHEMBL7795548 0.79 KDM4E (0.43) ALDH1A1KDM4EKMT2AMEN1MAPK1
SCHEMBL7801503 0.78 KCNN4 (0.41) ALDH1A1IDO1MAPTKMT2AMEN1
SCHEMBL3908445 0.78 POLB (0.44) ALDH1A1IDO1MAPTKMT2AMEN1
SCHEMBL7533377 0.77 HTT (0.49) IDO1MAPTADRA2BADRA2CKMT2A
SCHEMBL3088415 0.77 MEN1 (0.50) GAAMAPTKMT2AMEN1MAPK1
SCHEMBL526384 0.77 IDO1 (0.52) ALDH1A1IDO1MAPTKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010012899-A1 Oligomeric methine dyes CLARIANT FINANCE ( BVI) LIMITED 2001-08-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010012899-A1 Oligomeric methine dyes INMT, DDT, DDC ALDH1A1 604/4885KDM4E 1276/4885GAA 2678/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.